Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

11,910 total articles

Altimmune CEO Purchases $70,790 in Stock Amid Weak Q4 Results

Altimmune CEO Purchases $70,790 in Stock Amid Weak Q4 Results

Altimmune President and CEO Jerome Benedict Durso acquired 20,000 shares of the company on March 6, 2026, paying a weighted average of $3.5395 per share for a total of $70,790. The purchase occurred while the stock traded near $3.54 after a 15% decline over the prior week. The company recently reported fourth-quarter 2025 results that missed expect…

Quantum-Si Director Adds 500,000 Shares in $459,800 Purchase

Quantum-Si Director Adds 500,000 Shares in $459,800 Purchase

Quantum-Si Inc. director Charles R. Kummeth purchased 500,000 shares of Class A Common Stock on March 5, 2026, paying a weighted average of $0.9196 per share for a total outlay of $459,800. The trade leaves Kummeth with 855,000 directly held shares. The company's shares are trading near their 52-week low and recent quarterly results showed mixed ou…

Orthofix CP&BOO Vitale Lucas Sells 2,312 Shares to Cover RSU Taxes

Orthofix CP&BOO Vitale Lucas Sells 2,312 Shares to Cover RSU Taxes

Vitale Lucas, Chief Product and Business Operations Officer at Orthofix Medical Inc. (NASDAQ: OFIX), disposed of 2,312 shares across two transactions on March 4 and March 5, 2026, to satisfy tax obligations tied to restricted stock unit settlements. The trades occurred at weighted average prices of $12.9163 and $12.5508, respectively. Following the…

Veracyte CFO Disposes $662,869 in Shares Under Pre-Arranged Plan

Veracyte CFO Disposes $662,869 in Shares Under Pre-Arranged Plan

Veracyte Inc. Chief Financial Officer Rebecca Chambers sold 18,341 shares on March 4, 2026, for proceeds totaling $662,869. The sales were made under a Rule 10b5-1 plan adopted in August 2025. The transactions occurred as Veracyte reported stronger-than-expected fourth-quarter 2025 results and management reaffirmed 2026 guidance; analysts issued di…

22NW Fund Reduces Stake in L.B. Foster, Sells $163,906 of Shares

22NW Fund Reduces Stake in L.B. Foster, Sells $163,906 of Shares

22NW Fund, LP and affiliated entities disposed of 5,124 shares of L.B. Foster Company (NASDAQ: FSTR) common stock on March 4, 2026, generating $163,906 in proceeds. The sale took place close to the stock's 52-week peak, while the company reported fourth-quarter 2025 results that beat revenue expectations but missed earnings per share forecasts by a…

Nuveen Quality Municipal Income Fund VP Buys 100 Shares; Holds Just Over 1,041 Shares After Transaction

Nuveen Quality Municipal Income Fund VP Buys 100 Shares; Holds Just Over 1,041 Shares After Transaction

Nuveen Quality Municipal Income Fund (NYSE:NAD) Vice President William A. Siffermann purchased 100 shares on March 5, 2026, paying $12.0562 per share for a total outlay of $1,205. The purchase was disclosed in a Form 4 filed with the SEC on March 6, 2026. After the trade, Siffermann directly owns 1,041.3222 shares. The fund is trading close to its …